GSK, Sanofi restart testing for COVID-19 vaccine after delay

Pharma companies GlaxoSmithKline and Sanofi announced Monday that they have begun a second-stage clinical trial for their protein-based COVID-19 vaccine, after testing was delayed in December.

Share on FacebookEmail this to someoneShare on Google+Tweet about this on TwitterPrint this pageShare on LinkedInShare on StumbleUponShare on TumblrShare on RedditFlattr the authorPin on PinterestBuffer this pageDigg this